相关实验视频

Updated: Jul 25, 2025

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

阿尔茨海默病:基于酵母模型的显著益处

Khoren K Epremyan¹, Dmitry V Mamaev¹, Renata A Zvyagilskaya¹

¹A.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninsky Ave. 33/2, 119071 Moscow, Russia.

International journal of molecular sciences

|June 28, 2023

概括

单细胞酵母是阿尔茨海默病 (AD) 研究的宝贵模型. 这些有机体有助于了解粉样蛋白Aβ和病理,促进对AD的新治疗策略的发现.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
生物化学生化学

背景情况:

阿尔茨海默病 (AD) 是一种进展性神经系统疾病,其特点是蛋白质聚合 (粉样蛋白Aβ,tau),神经元损失和微质变化.
阿尔茨海默病是全球公共卫生优先事项,需要先进的研究模型来更好地理解和开发治疗方法.

研究的目的:

审查酵母模型在阿尔茨海默病研究中的实用性.
突出酵母和其他简单的真核模型对理解Aβ和tau生物学的贡献.
讨论酵母模型在识别早期AD生物标志物和开发治疗药物的未来潜力.

主要方法:

对阿尔茨海默病的酵母模型现有研究的审查.
对酵母与真核生物的生物学相似性和作为模型生物体的优势的分析.
检查酵母中与AD相关的因素和药物的高通量选能力.

主要成果:

酵母模型与C. elegans和Drosophila一起,大大提高了对粉样蛋白Aβ和生物学的理解.
酵母促进了对影响Aβ聚合和tau过酸化的化合物的高通量选.
在大规模研究中,酵母模型在简单性,基因操纵和成本效益方面具有优势.

结论:

酵母模型对于剖析基本的阿尔茨海默病机制至关重要.
基于酵母的高通量系统的持续开发将加速早期AD生物标志物的识别.
酵母研究对开发新型治疗策略来对抗阿尔茨海默病具有前景.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.氨基酸ββ的化物.线粒体功能障碍线粒体功能障碍甲基疗法治疗是如何进行的酸化的陶蛋白是一种酸化的陶蛋白.酵母模型的酵母模型

更多相关视频

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Yeast Signaling

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...